Titan Biotech Quarterly Results for Trading Insights
TITANBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹8 Cr
QSept 2025
Titan Biotech Quarterly Results Key Highlights
- Revenue of ₹56 Cr in Sept 2025 (+51.4% vs Mar 2025, +40.0% vs Sept 2024)
- Net Profit of ₹8 Cr in Sept 2025 (+100.0% vs Mar 2025, +14.3% vs Sept 2024)
- EBITDA of ₹11 Cr in Sept 2025 (+83.3% vs Mar 2025)
- Operating Margin of 17.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹9.40 in Sept 2025 (+91.8% vs Mar 2025)
Titan Biotech Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 56 | 37 | 47 | 40 | 40 | 51.4% | 40.0% |
| Net Profit (₹ Cr) | 8 | 4 | 7 | 7 | 5 | - | - |
| EBITDA (₹ Cr) | 11 | 6 | 10 | 8 | 8 | - | - |
| EPS (₹) | 9.40 | 4.90 | 8.30 | 8.10 | 6.05 | - | - |
| Operating Margin (%) | 17.0% | 13.0% | 19.0% | 19.0% | 18.0% | - | - |
Titan Biotech Share Price Trend Around Quarterly Results
Visualize Titan Biotech's 1-year price movement across quarterly results — ideal for logging trades in Titan Biotech share price
chart using Tickjournal. All values in ₹.
Related Pages for Titan Biotech
Additional stock information and data for TITANBIO
Revenue Trend (₹ Cr)
Sept 2024
40
Jun 2025
47
Mar 2025
37
Sept 2025
56
Net Profit Trend (₹ Cr)
Sept 2024
7
Jun 2025
7
Mar 2025
4
Sept 2025
8
Operating Margin Trend (%)
Sept 2024
19.0%
Jun 2025
19.0%
Mar 2025
13.0%
Sept 2025
17.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Titan Biotech quarterly results with other companies in Chemicals sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Sept 2025 |
₹149,084.93 Cr | 1464.9 | 3,605 | 585 | +11.9% | - | 16.2% | 257.5 |
|
SRF
Sept 2025 |
₹83,989.01 Cr | 2689.1 | 3,560 | 388 | -16.2% | - | 10.9% | 205.3 |
|
Coromandel Internat…
Sept 2025 |
₹67,477.25 Cr | 2274.8 | 9,771 | 793 | +78.9% | - | 8.1% | 83.2 |
|
UPL
Sept 2025 |
₹61,081.58 Cr | 752.4 | 12,411 | 612 | -20.8% | - | 4.9% | 111.5 |
|
Linde
Sept 2025 |
₹58,846.11 Cr | 6794.0 | 650 | 171 | +7.4% | - | 26.3% | 338.9 |
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores